1 郝阳.我国结核病防治概况与今后工作设想[J].中华结核和呼吸杂志,2004,27(7):433-434
2 张天民.莫苷沙星研究进展[J].临床肺科杂志,2000,5(4):242-243
3 马玙.耐多药肺结核的治疗[J].临床肺科杂志,2005,10(2):137-140
4 许国祥.抗结核药早期杀菌活性测定的研究进展[J].结核病与胸部肿瘤,2000,(3):207-210
5 张天民.抗结核药物的研究进展和瞻望[J].结核病与胸部肿瘤,2004,(2):147-151
6 张天民.氟喹诺酮类药物在老年肺结核中的作用[J].实用老年医学,2002,6(1):11-13
7 蒋耀先,唐扩军.氧氟沙星对儿童关节软骨影响的临床观察[J].中华儿科杂志,2000,38(9):591
8 Alvirez-Freites EJ,Carter JL,Cynamon MH.In vitro and vivo activities of gatifloxacin against mycobacterium tuberculosis[J].Antimicrobial Agents and Chemotherapy,2002,46:1022
9 Zhao Xilin.Clarification of mutant prevention concentration and the mutant selection window concept[J].J Antimicrob Chemother,2003,52(4):731-734
10 Nuermberge EL,Yoshimutsu T,Tyori S,et al.[J].Moxifloxacin-con-tainning regimen greatly reduces time culture conversion murine tubercu-losis[J].Am J Respir Crit Care Med,2004,169(3):401-406
11 Mwinge A,Fourie PB.Prospects for new tuberculosis treatment in Africa[J].Trop Med Int Health,2004,9(7):872-873
12 Kaczmarska L.Short-course treatment regimen to identify potential an-tituberculous agents in a murine model of tuberculosis[J]. Antibiotiki I Khimioterapiva,2004,49:185
|